Cargando…

Assessment of pulmonary (18)F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib

PURPOSE: To investigate effects of radiotherapy (RT) and erlotinib on pulmonary glucose uptake using 2-deoxy-2-(18F)fluoro-D-glucose ((18)F-FDG) positron emission tomography (PET) during and after treatment of non-small cell lung cancer (NSCLC) and to identify associations between serum cytokine lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abravan, Azadeh, Eide, Hanne Astrid, Knudtsen, Ingerid Skjei, Løndalen, Ayca Muftuler, Helland, Åslaug, Malinen, Eirik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833916/ https://www.ncbi.nlm.nih.gov/pubmed/29594209 http://dx.doi.org/10.1016/j.ctro.2017.04.002

Ejemplares similares

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
por: Eide, Hanne A., et al.
Publicado: (2018)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
por: Arnesen, Marius Røthe, et al.
Publicado: (2016)

Pelvic PET/MR attenuation correction in the image space using deep learning
por: Abrahamsen, Bendik Skarre, et al.
Publicado: (2023)

Positron emission tomography guided dose painting by numbers of lung cancer: Alanine dosimetry in an anthropomorphic phantom
por: Papoutsis, Iosif, et al.
Publicado: (2022)

Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
por: Huynh, Bao Ngoc, et al.
Publicado: (2023)

FDG PET/CT and Dosimetric Studies of (177)Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?
por: Løndalen, Ayca, et al.
Publicado: (2022)

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
por: Løndalen, Ayca, et al.
Publicado: (2020)

The Search Conference as a Method in Planning Community Health Promotion Actions
por: Magnus, Eva, et al.
Publicado: (2016)

Physiological uptake in FDG PET simulating disease
por: Ahmad Sarji, S
Publicado: (2006)

Cultural activity participation and associations with self-perceived health, life-satisfaction and mental health: the Young HUNT Study, Norway
por: Hansen, Elisabeth, et al.
Publicado: (2015)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

Prognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib
por: Kus, Tulay, et al.
Publicado: (2015)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

FDG Uptake in PET by Bladder Hernia Simulating Inguinal Metastasis
por: Park, Sung Hee, et al.
Publicado: (2007)

Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET
por: Lindholm, Henry, et al.
Publicado: (2014)

(18)F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET
por: Watabe, Tadashi, et al.
Publicado: (2020)

Mass-like Appearance on (18)F-FDG PET/CT: Cascade Stomach
por: Arçay, Ayça, et al.
Publicado: (2022)

Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by (18)F-FDG PET/CT Imaging
por: Vlachopoulos, Charalambos V., et al.
Publicado: (2020)

Pattern of FDG-PET uptake in lipoid pneumonia simulating lung cancer
por: Nakagawara, Kensuke, et al.
Publicado: (2020)

Pancreatic FDG uptake on follow-up PET/CT in patients with cancer
por: Iwasa, Hitomi, et al.
Publicado: (2021)

Significance of FDG–PET standardized uptake values in predicting thyroid disease
por: Kikuchi, Tomohiro, et al.
Publicado: (2022)

Leisure time activities in adolescence in the presence of susceptibility genes for obesity: risk or resilience against overweight in adulthood? The HUNT study
por: Cuypers, Koenraad, et al.
Publicado: (2012)

Neurolymphomatosis with Spinal Nerve Root Involvement Demonstrated on (18)F-FDG PET/CT
por: Arçay, Ayça, et al.
Publicado: (2022)

In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8
por: Renard, Dimitri, et al.
Publicado: (2016)

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on (18)F-FDG-PET/CT
por: Amrane, Karim, et al.
Publicado: (2022)

Etiology and significance of incidentally detected focal colonic uptake on FDG PET/CT
por: Purandare, Nilendu C, et al.
Publicado: (2012)

Drug injection-related fat necrosis of the breast with FDG PET-CT uptake
por: Toney, Lauren Kay, et al.
Publicado: (2015)

(18)F-FDG-PET uptake in non-infected total hip prostheses
por: Gelderman, Stefan J, et al.
Publicado: (2018)

Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome
por: Kim, Honsoul, et al.
Publicado: (2016)

A case of pancreatic schwannoma showing increased FDG uptake on PET/CT
por: Fukuhara, Sotaro, et al.
Publicado: (2017)

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT
por: Dong, Aisheng, et al.
Publicado: (2016)

False-Positive (18)F-FDG PET/CT Uptake in Unilateral Lactation
por: Yip, Joshua Wei Liang, et al.
Publicado: (2020)

Takayasu arteritis: clinical importance of extra-vessel uptake on FDG PET/CT
por: Tsuchiya, Junichi, et al.
Publicado: (2019)

Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity
por: Seong, Hye, et al.
Publicado: (2021)

Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients()
por: Winther-Larsen, Anne, et al.
Publicado: (2016)

Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET
por: Abourbeh, Galith, et al.
Publicado: (2015)

What is the importance of solitary focal bony FDG-uptake on 18F-FDG PET-CT of known cancer patients?
por: Sonoda, LI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_amfk5ad0d95u6vt6vb1r5oc2d7